Xarelto to Blame for Bleeding Deaths | News | HMG LLP

Uncontrollable Bleeding Lead to Deaths: Xarelto® to Blame

August 31, 2017

Uncontrollable Bleeding Led to Deaths: Xarelto® to Blame

The anticoagulant Xarelto®, made by the pharmaceutical giant Janssen Pharmaceuticals and Bayer Healthcare AG, is coming under fire for causing deaths and injuries to dozens of patients in the U.S. Often prescribed for atrial fibrillation and other medical conditions, this drug is a blood thinner that has caused hemorrhaging and internal bleeding in many patients. The manufacturer failed to notify patients of the serious risks associated with taking this potentially dangerous drug.

Xarelto Sold as an Alternative to Warfarin

Xarelto was first released for sale in 2011 as an alternative medication to Warfarin for atrial fibrillation. While Warfarin had been prescribed as a blood thinner for decades, it also requires constant blood monitoring. Xarelto was marketed as a safe, easier alternative that would not require this monitoring.

The FDA first approved Xarelto in July 2011 for deep vein thrombosis and pulmonary embolism. Later in November 2011, it also approved Xarelto for treatment of atrial fibrillation to help reduce blood clots and stroke risks. Both Xarelto and Pradaxa are newer blood thinners than Warfarin, but are costlier and pose serious risk for uncontrollable bleeding.

Uncontrollable Bleeding with Xarelto

Although all blood thinners have the potential to cause internal bleeding, the drugs Xarelto and Pradaxa® have the additional danger of having no antidote. Once a patient begins to bleed uncontrollably, there is little that can be done to stabilize his or her condition. This bleeding can lead to serious health risks, including cerebral and internal hemorrhaging that can then lead to death.

There have already been dozens of deaths and serious health conditions attributed to the use of Xarelto. In addition, there is substantiated concern within the medical community about the dangers of this drug. The Institute of Safe Medicine Practices (ISMP), which monitors adverse drug reactions reported to the FDA, reported that Xarelto had an increase in reported adverse reactions in 2013. The reports surpassed those for the similar drug Pradaxa, which is already the focus of a class-action lawsuit for causing uncontrollable bleeding and deaths.

Lawsuits Filed Against Xarelto

In May 2014, Pradaxa opted to settle for $650 million in a multidistrict lawsuit for over 4,000 victims of the drug. About this same time, the lawsuits began to pour in against Xarelto. Several lawsuits have already been filed, with many more expected to file over the next months and years. In June 2014, a woman in Florida filed a lawsuit against Bayer for the death of her husband who died from a subdural hemorrhage after taking Xarelto. Throughout the summer of 2014, more victims and their families came forward to demand that the drug being taken off the market and that the company pay for the pain, suffering and financial costs that have been caused by Xarelto.

“Anyone who has taken Xarelto or has a loved one that has used this medication should be aware of the dangers from uncontrollable bleeding, said Robert Hilliard, a trial attorney supporting victims of Xarelto™s my mission to ensure the victims and victim’s families are fairly represented.â€

Victims of uncontrollable bleeding caused by this dangerous drug are encouraged to contact a qualified personal injury attorney to discuss their case. Victims or their loved ones may be entitled to financial compensation for death or injury caused by Xarelto. 

the timing of your case is vital